Institutional shares held 54.5 Million
1.1M calls
808K puts
Total value of holdings $84.4M
$1.7M calls
$1.25M puts
Market Cap $156M
103,007,000 Shares Out.
Institutional ownership 52.88%
# of Institutions 171


Latest Institutional Activity in HUMA

Top Purchases

Q2 2025
Marshall Wace, LLP Shares Held: 2.64M ($3.99M)
Q2 2025
Center Book Partners LP Shares Held: 3.43M ($5.18M)
Q2 2025
Millennium Management LLC Shares Held: 2.55M ($3.85M)
Q2 2025
Ubs Group Ag Shares Held: 2.45M ($3.69M)
Q2 2025
Two Sigma Investments, LP Shares Held: 1.54M ($2.32M)

Top Sells

Q2 2025
Citadel Advisors LLC Shares Held: 625K ($943K)
Q2 2025
Woodline Partners LP Shares Held: 2M ($3.02M)
Q2 2025
Bank Of America Corp Shares Held: 503K ($760K)
Q2 2025
Exodus Point Capital Management, LP Shares Held: 10.1K ($15.2K)
Q2 2025
National Bank Of Canada Shares Held: 653K ($986K)

About HUMA

Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs). Its investigational HAVs are designed to be easily implanted into any patient without inducing a foreign body response or leading to immune rejection. The company is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; and coronary artery bypass grafting, as well as developing its HAVs for pediatric heart surgery and cellular therapy delivery, including pancreatic islet cell transplantation to treat Type 1 diabetes. The company was founded in 2004 and is headquartered in Durham, North Carolina.


Insider Transactions at HUMA

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
122K Shares
From 10 Insiders
Open market or private purchase 114K shares
Exercise of conversion of derivative security 8.2K shares
Sell / Disposition
8.38M Shares
From 3 Insiders
Open market or private sale 8.38M shares

Track Institutional and Insider Activities on HUMA

Follow Humacyte, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HUMA shares.

Notify only if

Insider Trading

Get notified when an Humacyte, Inc. insider buys or sells HUMA shares.

Notify only if

News

Receive news related to Humacyte, Inc.

Track Activities on HUMA